NEPHROTIC SYNDROME DURING TREATMENT WITH ALPHA-MERCAPTOPROPIONYLGLYCINE

被引：25

作者：

RIZZONI, G

PAVANELLO, L

DUSSINI, N

CHIANDETTI, L

ZACCHELLO, G

机构：

来源：

JOURNAL OF UROLOGY | 1979年 / 122卷 / 03期

关键词：

D O I：

10.1016/S0022-5347(17)56420-4

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

We report 2 cases of cystinuria in which a nephrotic syndrome developed during treatment with alpha-mercaptopropionylglycine. This syndrome resolved after withdrawal of the drug and it did not recur when the alpha-mercaptopropionylglycine was given again in lower doses. The hypothesis is made that the nephrotic syndrome was dose-related. The alpha-mercaptopropionylglycine must be used in doses <50 mg./kg. per day with regular monitoring of 24-hour urinary protein in cystinuric children.

引用

页码：381 / 382

页数：2

共 13 条

[1]

BIANCHI M, 1975, MINERVA PEDIATR, V27, P191

[2]

CARMIGNANI G, 1973, ARCH INT UROL NEFROL, V45, P6

[3]

CHIUSOLI E, 1970, P INT S THIOLA OSAKA, P9

[4]

DISCHE FE, 1976, J RHEUMATOL, V3, P145

[5] MERCAPTOPROPIONYLGLYCINE - PROGRESS IN CYSTINE STONE THERAPY [J].

HAUTMANN, R ;

TERHORST, B ;

STUHLSATZ, HW ;

LUTZEYER, W .

JOURNAL OF UROLOGY, 1977, 117 (05) :628-630

[6]

KING JS, 1968, P SOC EXP BIOL MED, V129, P927

[7]

KINOSHITA K, 1972, JAP J CLIN MED, V30, P2324

[8]

MANTERO O, 1972, P INT S THIOLA MONTE, P126

[9]

NEILD GH, 1975, LANCET, V1, P1201

[10]

REMIEN A, 1975, European Urology, V1, P227

← 1 2 →